This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Osaka University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Susumu Uchiyama: Innovator in Molecule Delivery Characterization
Introduction
Susumu Uchiyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of molecular delivery systems. His innovative work focuses on methods for characterizing molecule delivery particles, which are crucial for various applications in biotechnology and pharmaceuticals.
Latest Patents
Uchiyama holds a patent for a "Method for characterizing molecule delivery particles." This patent outlines a method that involves determining the molar concentration of molecule delivery particles. The process includes subjecting the particles to optical measurement for particle separation. This allows for the determination of the increment in refractive index of each particle involved. The method also provides a way to calculate the molar concentration based on the refractive index increment, molecular weight, and specific refractive index increment of the particles.
Career Highlights
Uchiyama is affiliated with Osaka University, where he conducts his research and development activities. His work has garnered attention for its potential applications in enhancing drug delivery systems. He has been recognized for his innovative approach to solving complex problems in molecular characterization.
Collaborations
Uchiyama collaborates with Tetsuo Torisu, a fellow researcher. Their partnership has contributed to advancements in the understanding of molecule delivery systems.
Conclusion
Susumu Uchiyama's contributions to the field of molecular delivery characterization highlight his role as an innovator. His patented methods pave the way for advancements in biotechnology and pharmaceuticals. His work continues to influence the development of effective drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
